Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTOR | P42345 | 11/20 | 0.51 |
| ▸ | PIK3CA | P42336 | 10/20 | 0.51 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.32 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.32 |
| ▸ | MAPK13 | O15264 | 4/20 | 0.31 |
| ▸ | MAPK12 | P53778 | 4/20 | 0.31 |
| ▸ | MAPK11 | Q15759 | 4/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.31 |
| ▸ | ABL1 | P00519 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2789910 | 0.83 | MTOR (0.71) | MTORPIK3CAMAPK13MAPK12MAPK11 | |
| SCHEMBL11028255 | 0.81 | MTOR (0.53) | MTORPIK3CACSNK1DCSNK1E | |
| SCHEMBL11031102 | 0.80 | MTOR (0.77) | MTORPIK3CA | |
| SCHEMBL11029468 | 0.78 | MTOR (0.76) | MTORPIK3CACSNK1DCSNK1E | |
| SCHEMBL2789558 | 0.74 | MTOR (0.77) | MTORPIK3CAABL1 | |
| SCHEMBL755585 | 0.73 | MTOR (0.81) | MTORPIK3CAMAPK13MAPK12MAPK11 | |
| SCHEMBL757661 | 0.71 | MTOR (0.78) | MTORPIK3CAABL1 | |
| SCHEMBL756436 | 0.71 | MTOR (0.76) | MTORPIK3CACSNK1DCSNK1EABL1 | |
| SCHEMBL757042 | 0.70 | MTOR (0.78) | MTORPIK3CA | |
| SCHEMBL2787359 | 0.70 | MTOR (1.00) | MTORPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2430013-A1 | HETEROARYL COMPOUNDS AS PIKK INHIBITORS | Amgen, Inc (US) | 2012-03-21 | — | — | EP | claimed |